What does Dr. Kirsten Robberecht, oogarts do?

Dr. Kirsten Robberecht, oogarts is a specialist medical practice in Opwijk. Private Limited, started on 10 March 2011, 1 establishment.

What is the address of Dr. Kirsten Robberecht, oogarts?

The registered office of Dr. Kirsten Robberecht, oogarts is located at Kalkestraat 68, 1745 Opwijk.

Is Dr. Kirsten Robberecht, oogarts still active?

Yes. According to the CBE (17 September 2026) Dr. Kirsten Robberecht, oogarts is active, legal situation “Normale toestand”, started on 10 March 2011.

Is Dr. Kirsten Robberecht, oogarts registered on Peppol?

Yes, Dr. Kirsten Robberecht, oogarts is registered on the Peppol network with ID 0208:0834436956.

What is the enterprise number of Dr. Kirsten Robberecht, oogarts?

The enterprise number of Dr. Kirsten Robberecht, oogarts is BE0834436956.

When was Dr. Kirsten Robberecht, oogarts founded?

Dr. Kirsten Robberecht, oogarts was founded on 10 March 2011.

Who are the directors of Dr. Kirsten Robberecht, oogarts?

According to the 2025 annual accounts, the directors of Dr. Kirsten Robberecht, oogarts are: Kirsten ROBBERECHT.

Is Dr. Kirsten Robberecht, oogarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 March 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Kirsten Robberecht, oogarts make in 2025?

Dr. Kirsten Robberecht, oogarts posted a profit after taxes of € 395,893 in financial year 2025.

What is the revenue of Dr. Kirsten Robberecht, oogarts?

As a small company, Dr. Kirsten Robberecht, oogarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 559,691.

Dr. Kirsten Robberecht, oogarts (Private Limited)

Dossier Dr. Kirsten Robberecht, oogarts, printed on 17 September 2026 from databakkes.be/en/0834436956/dr-kirsten-robberecht-oogarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Kirsten Robberecht, oogarts from Opwijk, company number BE0834436956, closed financial year 2025 with a result of € 395,893 after tax. For that financial year Dr. Kirsten Robberecht, oogarts recorded a gross margin of € 559,691 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € 404,995 to € 395,893. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 2.1 million

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 395,893

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 17,936

▼ 92% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 131,479 paid out

33 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 48,095

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 19,702

▲ € 18,495 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 42,443

▲ 17% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 372,632 Gross margin 2022: € 372,632 First fiscal year in the series	€ 416,551 Gross margin 2023: € 416,551 ▲ 12% vs 2022 (€ 372,632) Favourable step	€ 470,106 Gross margin 2024: € 470,106 ▲ 13% vs 2023 (€ 416,551) Favourable step	€ 559,691 Gross margin 2025: € 559,691 ▲ 19% vs 2024 (€ 470,106) Favourable step	▲ 19%
Profit after taxes	€ 259,954 Profit after taxes 2022: € 259,954 First fiscal year in the series	€ 280,484 Profit after taxes 2023: € 280,484 ▲ 8% vs 2022 (€ 259,954) Favourable step	€ 404,995 Profit after taxes 2024: € 404,995 ▲ 44% vs 2023 (€ 280,484) Favourable step	€ 395,893 Profit after taxes 2025: € 395,893 ▼ 2% vs 2024 (€ 404,995) Unfavourable step	▼ 2%
Equity	€ 1,486,965 Equity 2022: € 1,486,965 First fiscal year in the series	€ 1,586,682 Equity 2023: € 1,586,682 ▲ 7% vs 2022 (€ 1,486,965) Favourable step	€ 1,863,856 Equity 2024: € 1,863,856 ▲ 17% vs 2023 (€ 1,586,682) Favourable step	€ 2,128,271 Equity 2025: € 2,128,271 ▲ 14% vs 2024 (€ 1,863,856) Favourable step	▲ 14%
Total debts	€ 30,416 Total debts 2022: € 30,416 First fiscal year in the series	€ 54,330 Total debts 2023: € 54,330 ▲ 79% vs 2022 (€ 30,416) Unfavourable step	€ 60,054 Total debts 2024: € 60,054 ▲ 11% vs 2023 (€ 54,330) Unfavourable step	€ 94,924 Total debts 2025: € 94,924 ▲ 58% vs 2024 (€ 60,054) Unfavourable step	▲ 58%
Cash	€ 8,872 Cash 2022: € 8,872 First fiscal year in the series	€ 191,462 Cash 2023: € 191,462 ▲ € 182,591 vs 2022 (€ 8,872) Favourable step	€ 211,481 Cash 2024: € 211,481 ▲ 10% vs 2023 (€ 191,462) Favourable step	€ 17,936 Cash 2025: € 17,936 ▼ 92% vs 2024 (€ 211,481) Unfavourable step	▼ 92%
Retained profit	€ 1,431,165 Retained profit 2022: € 1,431,165 First fiscal year in the series	€ 1,530,882 Retained profit 2023: € 1,530,882 ▲ 7% vs 2022 (€ 1,431,165) Favourable step	€ 1,808,056 Retained profit 2024: € 1,808,056 ▲ 18% vs 2023 (€ 1,530,882) Favourable step	€ 2,072,471 Retained profit 2025: € 2,072,471 ▲ 15% vs 2024 (€ 1,808,056) Favourable step	▲ 15%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 180,766 Dividend 2023: € 180,766 Unchanged (€ 0) Unchanged	€ 127,820 Dividend 2024: € 127,820 ▼ 29% vs 2023 (€ 180,766) Unchanged	€ 131,479 Dividend 2025: € 131,479 ▲ 3% vs 2024 (€ 127,820) Unchanged	▲ 3%
Balance sheet total	€ 1,517,381 Balance sheet total 2022: € 1,517,381 First fiscal year in the series	€ 1,641,012 Balance sheet total 2023: € 1,641,012 ▲ 8% vs 2022 (€ 1,517,381) Unchanged	€ 1,923,911 Balance sheet total 2024: € 1,923,911 ▲ 17% vs 2023 (€ 1,641,012) Unchanged	€ 2,223,195 Balance sheet total 2025: € 2,223,195 ▲ 16% vs 2024 (€ 1,923,911) Unchanged	▲ 16%

Key figures of Dr. Kirsten Robberecht, oogarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Kirsten Robberecht, oogarts?

What happened at Dr. Kirsten Robberecht, oogarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 395,893 (▼ 2% vs 2024). Source: NBB ↗
Mar 10, 2011 New establishment in Opwijk. KBO
Mar 10, 2011 Start of the company according to the CBE. KBO

In short

From € 259,954 profit in 2022 to € 395,893 profit in 2025.

Paid € 571,373 in corporate taxes since 2022.

Best year ever: 2024, with € 404,995 profit.

Paid out € 440,065 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Kirsten Robberecht, oogarts? We notify you, reason included.

Follow Dr. Kirsten Robberecht, oogarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Kirsten ROBBERECHT

Dr. Kirsten Robberecht, oogarts

OOGINSTITUUT

Luce Care

COPPENS OOGARTSEN MIDDELENVENNOOTSCHAP

Behind Dr. Kirsten Robberecht, oogarts is Kirsten ROBBERECHT. Kirsten ROBBERECHT is also behind OOGINSTITUUT, Luce Care and COPPENS OOGARTSEN MIDDELENVENNOOTSCHAP.

See the full network in the app

Directors

According to the 2025 annual accounts

Kirsten ROBBERECHT

Director

Also active at: OOGINSTITUUT, Luce Care, COPPENS OOGARTSEN MIDDELENVENNOOTSCHAP

Establishments

Establishment units

Physical locations of this company

Registered office

Kalkestraat 68

1745 Opwijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0834.436.956
VAT number: BE 0834.436.956
Registered office: Kalkestraat 68, 1745 Opwijk
Names & denominations: Dr. Kirsten Robberecht, oogarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 March 2011
Peppol: Active · Active since 16 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗